Celldex Therapeutics, Inc.
CLDX
Revenue
730.00k
▲35.00k▲5.04%
3 Months ChangeAssets
648.44M
▼-43.97M▼-6.35%
3 Months ChangeLiabilities
50.08M
▲13.08M▲35.34%
3 Months ChangeFree Cash Flow
-54.64M
▼-13.66M▼-33.32%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-08
Form 10-Q
ID: 0001410578-24-001219
2024-08-08
Form 8-K
ID: 0001171843-24-004603
2024-06-14
Form 8-K
ID: 0001104659-24-071512
2024-05-06
Form 10-Q
ID: 0001410578-24-000593
2024-05-06
Form 8-K
ID: 0001171843-24-002570
2024-03-01
Form 8-K
ID: 0001104659-24-029969
2024-02-26
Form 8-K
ID: 0001171843-24-000966
2023-11-08
Form 8-K
ID: 0001104659-23-115796
2023-11-06
Form 8-K
ID: 0001104659-23-114520
2023-11-02
Form 10-Q
ID: 0001410578-23-002169